Uso of specific dose of fondaparinux sodium for the treatment of ACS

Details for Australian Patent Application No. 2002351915 (hide)

International Classifications

Event Publications

20 March 2003 Complete Application Filed

Priority application(s): 01204323.8 13.11.01 EP

24 July 2003 Application Open to Public Inspection

Published as AU-B-2002351915

18 May 2006 Assignment before Grant

Sanofi - Synthelabo The application has been assigned to Glaxo Group Limited 2003

29 November 2007 Application Accepted

Published as AU-B-2002351915

3 April 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.